Archives of Clinical Infectious Diseases

Published by: Kowsar

A Case of Progressive Rhino-Orbital Mucormycosis Involving the Brain Via Direct Extension, Retrograde Perineural Spreading and Middle Cerebral Artery Vasculopathy

Bahaadin Siroos 1 , Zahra Sharify Bahram 1 , Omid Ghaemi 2 , Seyyed Mahdi Zia Ziabari 3 and Mojtaba Hedayat Yaghoobi 4 , *
Authors Information
1 Department of Neurology, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, IR Iran
2 Department of Radiology, Imam Khomeini Hospital, Tehran University of Medical Sciences Tehran, IR Iran
3 Department of Emergency Medicine, Poursina Hospital, Guilan University of Medical Sciences, Rasht, IR Iran
4 Department of Infectious Disease, Besat Hospital, Hamadan University of Medical Sciences, Hamadan, IR Iran
Article information
  • Archives of Clinical Infectious Diseases: June 30, 2014, 9 (3); e17580
  • Published Online: June 25, 2014
  • Article Type: Case Report
  • Received: January 16, 2014
  • Revised: April 10, 2014
  • Accepted: May 6, 2014
  • DOI: 10.5812/archcid.17580

To Cite: Siroos B, Sharify Bahram Z, Ghaemi O, Zia Ziabari S M, Hedayat Yaghoobi M. A Case of Progressive Rhino-Orbital Mucormycosis Involving the Brain Via Direct Extension, Retrograde Perineural Spreading and Middle Cerebral Artery Vasculopathy, Arch Clin Infect Dis. 2014 ; 9(3):e17580. doi: 10.5812/archcid.17580.

Copyright © 2014, Infectious Diseases and Tropical Medicine Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Introduction
2. Case Presentation
3. Discussion
  • 1. Spellberg B, Edwards J, Jr., Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev. 2005; 18(3): 556-69[DOI][PubMed]
  • 2. Ibrahim AS, Spellberg B, Walsh TJ, Kontoyiannis DP. Pathogenesis of mucormycosis. Clin Infect Dis. 2012; 54 Suppl 1-22[DOI][PubMed]
  • 3. Lee FY, Mossad SB, Adal KA. Pulmonary mucormycosis: the last 30 years. Arch Intern Med. 1999; 159(12): 1301-9[PubMed]
  • 4. Wali U, Balkhair A, Al-Mujaini A. Cerebro-rhino orbital mucormycosis: an update. J Infect Public Health. 2012; 5(2): 116-26[DOI][PubMed]
  • 5. Chamilos G, Lewis RE, Kontoyiannis DP. Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. Clin Infect Dis. 2008; 47(4): 503-9[DOI][PubMed]
  • 6. Barati M, Talebi Taher M, Nojomi M, Kerami F. Ten-year experience of rhinocerebral zygomycosis in a teaching hospital in Tehran. Arch J Clin Infect Dis. 2010; 5(3): 117-20
  • 7. Sun QN, Fothergill AW, McCarthy DI, Rinaldi MG, Graybill JR. In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes. Antimicrob Agents Chemother. 2002; 46(5): 1581-2[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments